Literature DB >> 33525434

Environmental Microbial Contamination during Cystic Fibrosis Group-Based Psychotherapy.

Martina Rossitto1, Paola Tabarini2, Vanessa Tuccio Guarna Assanti1, Enza Montemitro3, Arianna Pompilio4,5, Ersilia Vita Fiscarelli1.   

Abstract

Living with cystic fibrosis (CF) exposes patients to the risk of developing anxiety and depression, with therapeutic compliance reduction, hospitalization increase, and quality of life and health outcomes deterioration. As pulmonary infections represent the major cause of morbidity and mortality in patients with CF, environmental contamination due to droplet dispersion and the potential transmission from environment to such patients should be prevented. Therefore, in-person contact, including group-based psychotherapy, are strongly discouraged. Nevertheless, group sharing of disease-related experiences represents a way to recover the inner resources essential for dealing with a chronic pathology. Keeping in mind the guidelines for infection control, the aim of this study is to evaluate the risk of the dissemination of microorganisms in a restricted environment where patients with CF attend group psychotherapy sessions. Five patients, selected according to their microbiological status, attended 32 group-based psychological/psychoanalytic meetings. Before each session, they were asked to observe the infection control recommendations. Microbiological environmental monitoring (MEM) has been performed to evaluate both air and surface contamination. As reported, a strict observation of standard precautions allows one to avoid environmental contamination by pathogens of the CF respiratory tract. Although infection control guidelines discourage group-based psychological/psychoanalytic interventions, our observations report the feasibility and safety of group psychotherapy when strict precautions are taken.

Entities:  

Keywords:  cystic fibrosis; group-based psychological/psychoanalytic interventions; microbiological environmental monitoring

Year:  2021        PMID: 33525434      PMCID: PMC7908138          DOI: 10.3390/ijerph18031142

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  23 in total

Review 1.  The index of microbial air contamination.

Authors:  C Pasquarella; O Pitzurra; A Savino
Journal:  J Hosp Infect       Date:  2000-12       Impact factor: 3.926

2.  Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei.

Authors:  Michelle E Wood; Rebecca E Stockwell; Graham R Johnson; Kay A Ramsay; Laura J Sherrard; Timothy J Kidd; Joyce Cheney; Emma L Ballard; Peter O'Rourke; Nassib Jabbour; Claire E Wainwright; Luke D Knibbs; Peter D Sly; Lidia Morawska; Scott C Bell
Journal:  Thorax       Date:  2018-04-07       Impact factor: 9.139

3.  Examining the Stability of the Hospital Anxiety and Depression Scale Factor Structure in Adolescents and Young Adults With Cystic Fibrosis: A Confirmatory Factor Analysis.

Authors:  Estefany Saez-Flores; Niza A Tonarely; David H Barker; Alexandra L Quittner
Journal:  J Pediatr Psychol       Date:  2018-07-01

4.  Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families.

Authors:  Yolanda Miroballi; Elizabeth Garber; Haomiao Jia; Juyan Julia Zhou; Luis Alba; Lynne M Quittell; Denise Angst; Michael Cabana; Lisa Saiman
Journal:  Pediatr Pulmonol       Date:  2011-08-24

Review 5.  ECFS best practice guidelines: the 2018 revision.

Authors:  Carlo Castellani; Alistair J A Duff; Scott C Bell; Harry G M Heijerman; Anne Munck; Felix Ratjen; Isabelle Sermet-Gaudelus; Kevin W Southern; Jurg Barben; Patrick A Flume; Pavla Hodková; Nataliya Kashirskaya; Maya N Kirszenbaum; Sue Madge; Helen Oxley; Barry Plant; Sarah Jane Schwarzenberg; Alan R Smyth; Giovanni Taccetti; Thomas O F Wagner; Susan P Wolfe; Pavel Drevinek
Journal:  J Cyst Fibros       Date:  2018-03-03       Impact factor: 5.482

Review 6.  Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Ian J Clifton; Daniel G Peckham
Journal:  Expert Rev Respir Med       Date:  2010-08       Impact factor: 3.772

Review 7.  Skin Immunity to Candida albicans.

Authors:  Sakeen W Kashem; Daniel H Kaplan
Journal:  Trends Immunol       Date:  2016-05-10       Impact factor: 16.687

Review 8.  The skin microbiome.

Authors:  Elizabeth A Grice; Julia A Segre
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

Review 9.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

10.  Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.

Authors:  Luke D Knibbs; Graham R Johnson; Timothy J Kidd; Joyce Cheney; Keith Grimwood; Jacqueline A Kattenbelt; Peter K O'Rourke; Kay A Ramsay; Peter D Sly; Claire E Wainwright; Michelle E Wood; Lidia Morawska; Scott C Bell
Journal:  Thorax       Date:  2014-04-17       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.